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According to current immunologic doctrine, the specificity of allergic wheal- 
and-erythema responses in human skin is determined by soluble antibodies; e.g., 
those which occur in serum and in extravascular fluid. Not all antigen-antibody 
systems appear to be competent, however, to incite this response and the basis 
for the competency of some systems, and for the incompetency of others, has 
yet to be established.  To a  great extent the  difficulties which have been en- 
countered in attempts to elucidate the basis for competency have arisen from 
the multiplicity of antibody specificifies in antisera produced to protein anti- 
gens, even those which are exceedingly pure by usual standards.  As a  conse- 
quence, correlations between skin test responses and the amounts and charac- 
teristics of serum antibodies in test subjects have been difficult to interpret with 
confidence; i.e., because of uncertainty as to whether the specific determinants 
in skin tests are identical with those of the serum antibodies assayed. In passive 
transfer skin tests the use of whole serum, or ~,-globulin fractions of antiserum, 
leads, for the same reasons, to similar ambiguity. Under these circumstances the 
immune systems which offer the greatest promise for analysis of the immuno- 
logic  requirements  for  wheal-and-erythema  production  are  those  for  which 
highly purified antibodies can be obtained, and those in which the antigenic de- 
terminants are defined. On these grounds, certain naturally occurring polysac- 
charides  and  synthetic  organic  molecules,  and  their  homologous  antibodies, 
qualify as particularly suitable systems. 
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In the present work, wheal-and-erythema responses were studied in a human 
subject who had been actively sensitized with 2,4-dinitrophenyl antigens, and 
also in a number of other human subjects whose skin sites were passively sensi- 
tized with purified rabbit antibodies specific for the dinitrophenyl group. The 
determinant involved in the cutaneous reaction, both in the passively prepared 
sites and in the actively sensitized subject, was verified as  being the dinitro- 
phenyl group by means of specific inhibition  with appropriate DNP-containing 
substances) The effects of unifunctional  haptens and univalent antibody frag- 
ments, produced by papain digestion of purified antibodies, suggest that  the 
formation of multimolecular aggregates involving mutually multivalent anti- 
body and antigen is a  necessary condition for development of the wheal-and- 
erythema response in human skin. 
Materials and Methods 
Antigens.--The  methods used  to  prepare  DNP-protein  conjugates and to estimate  the 
number of DNP substituents per mole protein have been described previously (I). Crystal- 
lized ovalbumin was  obtained  from the  Pentex  Corp., Kankakee,  Illinois. Human serum 
albumin was kindly furnished by the American Red Cross, and bovine "y-globulin  was fraction 
II of bovine plasma supplied by Armour and Co., Chicago, Illinois. 
ttaptens.--Most of the low molecular weight dinitrobenzenes were obtained from commer- 
dal sources. Except for 2,4-dinitrofluorobenzene, they were recrystallized one to four times. 
Their melting points were in agreement with  data in the  literature.  Previously described 
methods were used to prepare ~-DNP lysine (2) and ¢-DNP aminocaproic acid (3).  1 
Antisera.--Rabbits were immunized by a single injection of 5 rag. EA or 5 rag. DNP-B'),G 
in Freund's complete adjuvant (0.2 to 0.4 ml. per footpad), and were usually bled 1 month 
later (4).1 Anti-EA sera from about ten rabbits were pooled, and antibody was concentrated 
from the pool as a "y-globulin  fraction prepared by precipitation at 1.75 M  ammonium sulfate, 
pH 7-8. Anti-EA antibody concentrations in the T-globulin fraction and anti-DNP antibody 
concentrations in pooled sera were determined by quantitative precipitin analyses (4-6). 
Purified  Antibodios.--Purified  anti-DNP antibody was  isolated from  pooled anti-DNP 
anfisera by the method described in the accompanying report (4). The purified antibody was 
generally lyophi]ized and stored at about 4  °. For use in skin testing, it was dissolved in 0.01 
phosphate, pH 7.4-0. 15 ~ NaC1 and sterilized by passage through millipore  2 or Seitz filters, 
which had been first fushed with phosphate-saline. The protein content of the sterilized solu- 
tion was determined from absorbance at 278 m/z (4). DNP-protein  conjugates and haptens 
were similarly sterilized, and concentrations, in most cases, were measured by absorbance at 
360 m/~. 
Papain  Digestion of Purified Antibody  and Rabbit "},-Globulin.--Purified anti-DNP anti° 
bodies and the "),-globulin  fraction of rabbit anti-EA sera, were digested with crystalline papain 
(Worthington Biochemical Corp., Freehold, New Jersey) under the conditions described by 
1  Abbreviations used: DNP is used generically for the 2,4-dinitrophenyl  group. Hence, 
~-DNP lysine and e-DNP aminocaproate are, respectively, ¢-N-2,4-dinitrophenyl lysine and 
¢-N-2,4-dinitrophenyl aminocaproic acid. EA is hens' egg albumin. B'yG is bovine "y-globulin 
(fraction II of bovine plasma). DN-P-B'yG is bovine v-globulin whose lysine  residues are 
almost maximally substituted with 2,4-dinitrophenyl groups. 
2 Millipore filter, type HA. MilIipore Filter Corp., Bedford, Massachusetts. F. S. FARAtZ~ M. KERN~ AND IL N. EISEN  1213 
Porter (7). When the digest was dialyzed in the cold against 10  -3 M phosphate, pH 6--7, frac- 
tion III was obtained as flat, crystalline plates (7). Mter centrifugation to remove this  crystal- 
line fraction, the supernatant  was considered to be a mixture of fractions  I  and II (Porter's 
terminology). Subsequent experience with  chromatography of this superuatant  on  carboxy- 
methyl cellulose ~ columns has yielded two fractions, essentially as described  by Porter (7). 
I131-Labding  of Proteins.--Purified antibody and  the fractions isolated from it by papain 
digestion and dialysis (fractions I  and II, and fraction III) were iodinated  with I ~1 (9,  10). 
Uncoupled I181-iodide ion was removed with an anion exchange resin  (amberlite, IRA-400, 
CI" form). More than 95 per cent of 1131 in the iodinated protein was precipitated with 5 per 
cent trichloracetic acid. In the case of fractions I and II, precipitation with trichloracetic acid 
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FIO. 1.  Direct tracings of some of the wheal-and-erythema responses  given in Tables I  to 
III. 
was unusually slow,  and often required standing overnight in the cold for completion. 1131 
was counted in a well-type scintillation counter. 
Skin Tests.--All injections were made intradermaUy with 26 gauge needles in volumes of 
either 0.05 or 0.1 ml. In passive transfer experiments, purified anfi-DNP antibody or antibody 
in the form of whole serum or "),-globulin fraction was injected in normal human volunteers, 
the sites were marked, and 31/'~ to 4 hours later the same sites were challenged by intradermal 
injection of DNP proteins or haptens, singly or together, or mixed with the papain-split anti- 
body fragments. For control purposes, identical injections of antigen were made at the same 
time in adjacent normal skin; i.e., not prepared with preceding injection of antibody. In a few 
experiments, sites injected with antibody were not challenged until 1 to 5 days later. 15 minutes 
after injection of test antigen, the margins of the response were outlined in ink using a solid 
line for the wheal and  a  broken line for the erythema.  A  record of the response was made 
either by direct measurement of the major and minor axes of the wheal and of the erythema, 
or by applying transparent tape 4 to the area. When the tape was removed, it carried with it 
the tracing on the skin and furnished a  permanent record of the response.  The results were 
8 Type 40 (reagent grade), Brown Paper Co., Berlin, New Hampshire. 
4 "Scotch tape." Minnesota Mining and Manufacturing Co. 1214  INHIBITION OF SKIN RESPONSES 
scored as follows: 0, a slightly raised bleb (no pseudopodia),  corresponding  in size to the orig- 
inal injection.  In an occasional subject,  such  blebs  were surrounded  by a narrow zone of 
erythema (at most 2 to 3 ram.).  ±, a bleb as in 0, but with slightly more erythema.  +, a 
typical wheal with pseudopodia up to 15 ram. average diameter with surrounding  erythema. 
+ +, a wheal of average diameter greater than 15 ram.,  with the surrounding  erythematous 
zone  being  two to three  times,  or  more,  greater  than  the  wheal.  The actual tracings  of 
some  critical  responses  in  Tables I  to III are given  in  Fig.  1, and the responses in these 
tables are recorded only in terms of the arbitrary scoring units,  0 to + +.  For the responses 
in Tables IV to VI, the actual measurements  of the wheal and erythema are given. 
RESULTS 
The present study became feasible when it was realized that one of us (HNE), 
who has been exposed over a period of years to protein-reactive 2,4-dinitroben- 
zenes,  gives wheal-and-erythema  reactions  on intradermal  injection  of DNP- 
protein conjugates. Systematic studies of the responses of this subject to a num- 
ber of DNP-contalning substances  are summarized in Table  I. Low molecular 
weight dinitrobenzenes  did not evoke a response although a DNP-protein  con- 
jugate,  having  as little  as  1  m/~eq.  DNP,  did3  Although  the  low  molecular 
weight substances did not elicit responses, they were immunologically reactive 
in the skin, their activity being demonstrated by inhibition  of the response to 
DNP-HSA.  The order of inhibitory effectiveness was ¢-DNP lysine  >  ~-DNP 
aminocaproate  >  2,4-dinitrophenol. 
Porter has shown that under certain conditions rabbit ~,-globulins are split by 
papain into three nearly equal pieces, designated as fractions I, II, and III (7). 
Fractions  I  and  II each  bear  one  of the  two  antigen-reactive  regions  of the 
intact  antibody molecules,  while fraction III, which is readily obtainable  as a 
crystalline protein, lacks these reactive regions (7, 8). When an unresolved mix- 
ture of I, II, and III (prepared by papain digestion of purified rabbit anti-DNP 
antibody)  was mixed with  DNP-HSA  and  injected,  the  wheal-and-erythema 
response was inhibited.  When III was separated from the digestion mixture by 
crystallization, the supernatant which consisted primarily of I +  II, was shown 
to account for the inhibitory activity of the total digest. Crystalline fraction III 
had no inhibitory activity (Table I). 
The  specificity  of  inhibition  by DNP-haptens  and  by  fraction  I  +  II of 
papain-digested  anti-DNP  antibody is apparent from their failure to influence 
wheal-and-erythema  responses to ragweed,  elicited in the same subject  (Table 
I). 
The responses obtained in the actively sensitized subject were duplicated  in 
all respects ill normal human subjects in whom skin sites were sensitized by in- 
tradermal injection of 5  to 140/zg.  of purified rabbit anti-DNP  antibody.  The 
passively conditioned  sites gave wheal-and-erythema  responses to DNP-HSA. 
A solution of a DNP-protein conjugate  has 10 m/zeq. DNP/ml. when its absorbance  at 
360 m/z is 0.174. F. S.  FARAH~ M.  KERN~ AND H.  N. EISEN  1215 
TABLE I 
Wheal-and-Erythema Responses of a Human Subject Sensitive to the 
2,4-Dinitrophenyl Group* 
Test No. 
1 
2 
3 
4 
5 
6 
7 
8 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Substance injected 
e-DNP lysine 
e-DNP-aminocaproate 
2,4-Dinitrophenol 
2,4-Dinitrobenzene sulfonate 
2,4-Dinitrochlorobenzene 
2,4-Dinitrofluorobenzene 
DNP-HSA 
DNP-HSA + 
e-DNP lysine 
DNT-HSA W 
2,4-dinitrophenol 
DNP-HSA 
DNP-HSA W 
e-DNP lysine 
DNP-HSA + 
e-DNP-aminocaproate 
D1WP-HSA + 
total  papain  digest  of  purified  anti- 
DNP antibody 
DNP-HSA 
DNP-HSA + 
fractions I  +  II of anti-DNP antibody 
DNP-HSA W 
fraction III of anti-DNP antibody 
Ragweed extract (100 units) 
Ragweed extract (100 units)  + 
e-DNP lysine 
Ragweed extract (100 units)  + 
e-DNP-aminocaproate 
Ragweed extract (100 units)  + 
fractions I  +  II of anti-DNP antibody 
Quantity 
As 
As DNP  protein 
m/~eq.  /~g. 
410 
420 
4600 
480 
4 
6 
1.5  4 
1.5  4 
460 
1.5  4 
4600 
5  10 
5  10 
110 
5  10 
450 
2.5  5 
-  280 
1  2 
1  2 
--  175 
1  2 
--  111 
190 
450 
--  436 
Reference 
Response  to tracin$ 
in Fig. 
0 
0 
0 
0 
0 
0 
++  a 
0  b 
4- 
++  c 
0 
4-  d 
0 
+ 
0 
+ 
+  e 
+  f 
+ 
+  g 
* All in ections were in 0.1  ml. volumes. Subject: H.  N.  E.  Mixtures of DNP-HSA (or 
ragweed extract)  and  papain  digestion products of anti-DNP antibody were incubated for 
30 minutes at 37 ° before injection. 
Extract of ragweed pollen, 1000 protein N  units/ml. The failure of haptens or papain- 
split antibody fragments to inhibit responses to ragweed was confirmed by testing another 
subject  (R. O.)  who gave large wheals on injection of 10 units of ragweed extract. 1216  INHIBITION OF SKIN RESPONSES 
MK 
~c 
~c 
FSF 
c~ 
wj 
AK 
4¢ 
TABLE  II 
Wheal-and-Erythema  Responses  in  Normal  Human  Skin  Produced  with  Rabbit 
Anti-2 , 4-Dinitrophenyl Antibodies and Their Specific Inhibition with Ha ~tens* 
Subject Tesl  No 
10 
11 
12 
13 
Skin site prepared with*, ~; 
1  Rabbit antiserum, ll 50/zl. 
2  Anti-DNP antibody, 170 #g. 
3  ......  ,  170  " 
4  Rabbit antiserum,[[ 50 #1. 
5  Anti-DNP antibody, 170 #g. 
6  "  ....  , 170  " 
Anti-DNP antibody, 56/zg. 
"  ....  ,56  " 
DNP-HSA 
DNP-HSA 
DNP-HSA + 
e-DNP lysine 
DNP-HSA 
DNP-HSA 
DNP-HSA + 
e-DNP lysine 
DNP-HSA 
DNP-HSA + 
e-DNP lysine 
DNP-HSA +  "  "  "  ,56  " 
Anti-DNP antibody, 23 #g. 
"  "  "  ,23  " 
,,  ,,  ,,  ~  ,, 
Tested  with 
e-DNP aminoca- 
proate 
"/-Globulin  fraction  of  rabbit 
anti-EA, 22 #g. 
DN'P-HSA 
DNP-HSA + 
e-DNP lysine 
DNP-HSA + 
2,4-dinitro- 
phenol 
DNP-HSA 
Quantity 
Substance  As  As 
DNP  Peri~ 
ml~eq.  I.Lg. 
5'10 
5  i0 
[  5  10 
5  10 
5  10 
110  -- 
5  10 
440  -- 
5  10 
Refer- 
h 
i 
J 
k 
-t-+  1 
0 
+ 
0 
* Sites were prepared by intradermal injection with 0.05  to 0.1  ml. aati-DNP  antibody 
or a 7-globulin fraction of rabbit anti-EA serum. 3 to 4 hours later 0.1 ml. of a test substance 
was injected into each site and,  for control purposes, into  an unprepared  site in the same 
recipient. 
Anti-DNP antibody refers to purified antibody, about 90 per cent specifically precipit- 
able  (see reference 4). The purified antibody used in tests 2, 3,  5,  and 6 had been prepared 
from the same antiserum (pool VI) used in tests 1 and 4. 
§ Actual tracings of the responses are given above the corresponding letter in Fig. 1. 
[I The  antiserum  (pool  VI)  contained  1.87  mg.  antibody/ml.,  precipitated  with  DNP- 
BTG. Hence 50/tl. had 89 #g. anti-DNP antibody (i.e.  95  per cent  of the antibody precipi- 
tated with this antigen is anti-DNP; see reference 4). Other sites prepared with 50/zl. of this 
pool were tested 21 hours later with DNP-HSA, and were also negative. F.  S.  FARAH~ M.  KERN~  AND H.  N.  EISEN  1217 
These reactions were inhibited  in descending order of effectiveness by e-DNP 
lysine, E-DNP aminocaproate, and by 2,4-dinitrophenol (Table II). They were 
also inhibited by a papain digest of purified rabbit anti-DNP antibody, and by 
the same digest from which fraction III had been removed (by crystallization at 
TABLE III 
Specific Inhibition by Univalent Antibody Fragments of Wheal-and-Erythema Responses in 
Human Skin Produced with Rabbit Anti-g,4-Dinitrophenyl 
Antibodies* 
Subject 
AdeW 
c¢ 
WW 
~c 
Tes 
No  Skin sites prepsredwith 
Anti-DNP antibody,  140 #g. 
Total  papain  digest  of  anti- 
DN-P antibody,  120 #g. 
Anti-DNP antibody, 140 #g. 
4  Anti-DNP antibody,  110/zg. 
5  "  "  "  110  " 
6  I  "  "  "  I10  " 
Tested with 
Substance 
DNP-HSA 
DNP-HSA 
DNP-HSA % 
total papain 
digest  of anti- 
DNP antibody 
DNP-HSA 
DNP-HSA % 
fractions 1% II 
of anti-DNP 
antibody 
DNP-HSA % 
fractions 1% 
II of rabbit 
anti-EA 7- 
globulin 
As 
'~*q'l  ~g"  I 
10 
.5  5 
280 
5  10 
5  lol 
218 
5[lo 
--  210 
Refer- 
ence to 
Lesult tracing 
in 
Fig. i~ 
++  m 
0 
+  n 
++  o 
4-  p 
-{-W  q 
* Sites were prepared  initially  by intradermal  injection  of 0.1 ml. purified rabbit anti- 
DNP antibody or a papain  hydrolysate  of the same antibody.  3 to 4 hours later  the sites 
were reinjected with 0.1 m]. of antigen  (DNP-HSA),  or antigen mixed with papain-digested 
anti-DNP antibody,  or anti-EA T-globulin fraction, or fractions 1% II of the corresponding 
papain hydrolysates. 
:~ Tracings of the responses are given above the corresponding letter in Fig. 1. 
pH 6-7).  The specificity of the inhibition  by papain-split  products is evident 
from the absence of inhibition by fractions I  q- II obtained by papain digestion 
of the "r-globulin fraction of rabbit anti-EA (Table III). 
As expected from the foregoing results, sites injected with the T-globulin frac- 
tion of rabbit anti-EA serum did not respond to subsequent injection of DNP- 1218  INHIBITION OF SKIN RESPONSES 
HSA (Table II). What is especially interesting, however, is that sites injected 
with a  papain  digest of anti-DNP  antibody did not respond  to  DNP-HSA 
(Table III). In view of the latter observation, comparison was made of the rates 
at which purified antibody and the fragments split from it by papain disappeared 
from skin sites. For this purpose, two normal human volunteers were injected 
intradermally with the several proteins labeled with I m (see Methods), and I  TM 
at the skin sites was measured, with time, using a collimated probe-type scintil- 
100~. 
!  "\ 
-~  o 
...  ~.. 
\"  °oo 
6  12  18 
HOURS 
Fzo. 2.  Disappearance  from human  skin of purified rabbit  anti-DNP  antibody  and  the 
fragments split from this antibody by papain. One volunteer (R. P.) was injected intradermally 
with 150/zg.  IlS]-antibody (~4 #c.). A second volunteer (W. G.) was injected in one site with 
250 #g. IlSl-fractions I  +  II (~-~1/~c.) and in another site with 80 #g. IlSLfraction III (~1 
~zc.). The zero time values at the injected sites were 30,000, 5400, and 1800 C.l~.~., respectively. 
A standard was counted at each time point to correct for radioactive decay and instrument 
fluctuation. The curve is drawn for a  1st order process with half-life 10 hours. Purified anti- 
body (O). Fractions I  +  II (O). Fraction III (4)). 
lation counter. The results, shown in Fig. 2, demonstrate little, if any, difference 
in the rates at which the several I131-proteins disappear from inoculated intra- 
dermal sites over the period of interest in these experiments. 
It is important to note that in two subjects skin sites which were prepared 
with unfractionated anti-DNP serum (0.05 ml. containing about 90 #g. anti- 
DNP antibody) did not react to DNP-HSA. In these same subjects, however, 
purified anti-DNP antibody isolated from the same serum was competent in 
preparing sites for the wheal-and-erythema response (Table II). The incompe- 
tence  of  whole  antiserum  could  arise  from competition between  anti-DNP 
antibodies and other ~,-globulins  in serum for some unknown reactant in skin. 
This possibility was evaluated by comparing the capabilities of mixtures which F. S. FARAH, M. KERN, AND H. N. EISEN  1219 
contained  a  constant  amount  of  purified  anti-DNP  antibody  and  varying 
amounts of a "y-globulin fraction prepared from rabbit anti-EA serum. The re- 
suits are given in Table IV. 
It has been suggested that non-precipitating antibodies are uniquely compe- 
tent  to mediate wheal-and-erythema responses  (11).  With  this  suggestion in 
mind, anti-DNP antibody purified from a specific precipitate made in the anti- 
body excess region of a  precipitin curve was compared with antibody purified 
from an equivalence region precipitate. The latter preparation is expected to be 
contaminated with non-precipitating anti-DNP antibodies, if they exist in the 
TABLE IV 
Interference by  Indifferent  Rabbit T-Globulins in  Wheal-and-Erythema Responses Produced 
by DNP-Protdn and Purified Rabbit Anti-DNP Antibody* 
Skin sites prepared  with  Responses$ 
Purified anti-DNP  "}'-Globulin  fraction 
of rabbit anti-EA  Wheal  Erythema  Rating  antibody  serum§ 
Izg. 
56 
56 
56 
56 
0 
56 
380 
76O 
tl~m. 
12 X 10 
15 X  12 
0 
0 
25 X  18 
35 X  19 
10 X 16 
10 X 12 
+ 
+ 
0 
0 
* Subject: WJ. 
15 minutes after injection of 0.1 ml. DNP-HSA (5 m#eq. DNP, 10 #g. protein) intra- 
dermal]y in skin sites which had been injected 4 hours previously with 0.1 ml. containing the 
substances shown in the first two columns. 
§ For inability of T-globulin of rabbit anti-EA serum to prepare sites for specific  response 
to DNP-HSA, see Table II, test 13. 
present anti-DNP sera. As shown in Table V, both preparations were equally 
competent in preparing skin for wheal-and-erythema responses. 
One further attempt was made to test the possibility that something other 
than  precipitating  anti-DNP  antibody prepares  skin  sites  for DNP-specific 
wheal-and-erythema responses. In this experiment purified antibody was pre- 
cipitated with DNP-B'yG, and the antibody was reisolated from the precipitate 
by the procedure previously described  (4).  This twice purified antibody was 
similarly precipitated, and from the precipitate a three times purified antibody 
was obtained. The once, twice, and three times purified preparations were found 
to be essentially indistinguishable (see Table V), although 90 per cent of the pro- 
tein present in the once purified antibody was sacrificed in obtaining from it the 
twice and three times purified proteins. 
The persistence of responsiveness in passively prepared skin sites was exam- 
ined in four subjects in whom comparison was made of the responses to DNP- 1220  INHIBITION OF SKIN RESPONSES 
HSA 4 hours and 1 to 5 days after injecting sites with anti-DNP antibody. The 
results of this comparison, summarized in Table VI, are compatible with the 
decay data of Fig. 2 and with the fact that sites given as little as 5 #g. purified 
antibody react (3 to 4 hours later) to DNP-HSA (Table V). 
TABLE  V 
Comparison of Skin-Sensltizing  Ability  of Rabbit Anti-2,4-Dinitrophenyl  Antibody  Isolated 
from Precipitates of Varying Antigen-Antibody Composition and Subjected 
to Successive Purification Cycles 
Antibody  injected* 
Preparation 
Isolated from pre- 
cipitate in anti- 
body excess 
Amount 
/zg. 
140 
70 
26 
13 
7 
130 
65 
24 
12 
7 
Response~t 
15 40 
18 32 
13127 
15 37 
15 46 
1(3 50 
1144 
Isolated from pre- 
cipitatein  equiv- 
alence region 
Erythema 
43  X40 
65  X  25 
30  X  30 
X  35 
X  16 
X  32 
X  31 
X  24 
X  30 
X  15 
Antibody  injected§  ResponseS: 
Preparation 
Once purified 
Twice purified 
Amount t  Wheal 
I.zg.  ram. 
23  12  X  17 
12  15  X  13 
4.6  12  X  11 
2.3  0 
28  17  X  12 
14  16  X  14 
5.6  17  X  11 
2.8  0 
24  18  X  14 
12  10  X  10 
4.8  0 
2.4  0 
Wheal 
14  X  15 
13  X  12 
12  X  11 
10  X 
12  X 
15  X 
15  X 
14  X 
16  X 
14  ×  Three times 
purified 
Erythem 
25  X  4~ 
35X2 
15X1 
16  X  1, 
19X4 
40X2 
25X1 
16X1 
35X2 
13X1 
15X1 
13X1 
* The  precipitate  in "antibody excess" contained  one-fourth  the  amount of  antibody 
maximally precipitable at equivalence region. The precipitate in equivalence region contained 
the maximal amount of antibody that could be precipitated from the given volume of anti- 
serum.  Subject:  JW. 
:~ 4 hours after injecting the indicated amounts of purified antibody intradermally  each 
site was reinjected with DNP-HSA (2.5 m#eq. DNP, 5 pg. protein). 
§ For the distinction between once, twice, and three times purified antibody see text. 
Subject: AK. 
In one preliminary titration, the magnitude of the urticarial response varied 
only slightly with the amount of antigen injected into passively prepared sites. 
Several skin sites of a normal subject (E.H.) were first injected intradermally, 
each with  130 #g. purified anti-DNP antibody. 4  hours later 0.1 ml. aliquots 
containing  varying amounts of DNP-HSA (1 m/zeq. DNP =  2 #g. protein) were 
injected into the sites.  The results  (in millimeters; W  is wheal  and E  is  ery- 
thema) were as follows:--i m/zeq. DNP (12  X  10W; 32  X  30E), 5 m#eq. DNP 
(13  X  llW; 33  X  34E), 25 m/~eq.  DNP  (17  X  17W; 44  X  38E),  50 m/~eq. 
DNP (16 X  14W; 44 X  31E). ~'. S.  ~'ARAH~ M.  KERN~  AND H.  N.  EISEN  1221 
Serum from the actively sensitized human subject (Table I) did not precipi- 
tate with DNP-protein added to it in widely varying amount and kept at near 
4 ° for up to I  month. This serum did not, moreover,  passively sensitize the skin 
of  normal recipients  (to  DNP-protein)  when injected undiluted  (0.1  ml.).  A 
TABLE VI 
Persistence of Wheal-and-Erythema Reactivity in Sites Pozsively Sensitized with 
Purified Rabbit A nti-2,4-Dinitrophenyl Antibody 
Subject 
MK 
FSF 
L~ 
AdeW 
EH 
cc 
cc 
Amount anti-DNP 
antibody injected 
/zg. 
170 
170 
170 
170 
140 
140 
130 
130 
130 
Time  of test injection* 
4 hrs.~ 
1 day 
4 hrs.§ 
1 day 
4 hrs.ll 
2 days 
5hrs. 
3 days 
5  " 
Wheal 
14X  11 
13X8 
15  X  10 
15  X  10 
17  X  16 
15  X  10 
13  X  11 
10X8 
0 
Response 
Erythema 
from. 
27  X  38 
43X20 
50X40 
42  X  42 
82  X  50 
67  X  35 
33  X  34 
19  X  19 
0 
* Tests made with 0.1  ml.  DNP-HSA  (5  rn#eq.  DNP,  10 #g.  protein)  injected intra- 
dermally, after the indicated period,  into sites previously injected with antibody. 
:~ Test 2, Table II. 
§ Test 5, Table II. 
[] Test 1, Table III. 
crude attempt was made, therefore, to isolate and  concentrate anti-DNP anti- 
body from this serum by the following procedure: 
60 ml. serum was mixed with 60 rag. of DNP-BTG (60 moles DNP per 160,000 gin. protein) 
that had been made virtually insoluble by treatment with a detergent (12). 35 rag. of strepto- 
mycin sulfate was added (4) and the mixture was kept for 60 minutes at 4 °. After centrifuga- 
tion the DNP-BTG sediment was washed and extracted at 37  ° with 0.1 ~  2,4-dinitrophenol 
in 0.01 ~  phosphate, pH 7.4-0.15 M NaC1 (4).  The extract was passed through a  Dowex-1 
column (C1- form), and the protein-containing effluent (3 ml.) was dialyzed overnight at 4 ° 
against phosphate-NaC1.  Absorbance at 278 m# indicated that the dialyzed material contained 
about 1 rag. protein/ml., but only 30 #g. protein/ml, was maximally precipitated in a precipi- 
tin analysis using DNP-BTG as test antigen. 0.1 ml. aliquots were injected into skin sites of 
six human recipients. Three of these gave a small wheal-and-erythema response on subsequent 
injection of DNP-HSA, but three other recipients failed to react. Assuming that the recovery 
of antibody from serum was about 40 per cent (4), we tentatively estimate that  this subject's 
serum contained about 3 #g. anti-DN-P antibody/m]. 1222  INHIBITION O~F SKIN RESPONSES 
DISCUSSION 
The most direct  and unambiguous means for  identifying  the antigenic  deter- 
minant of  an  antibody-dependent reaction  is  through inhibition  with  chemically 
defined  substances  that  are  structurally  related  to  the  immunizing agent (hapten 
inhibition).  The present work demonstrates  the applicability  of this  general 
method to wheal-and-erythema responses.  Hapten inhibition  of the response in 
human skin  sites  which had been prepared by local  injection  of purified  rabbit 
antibody is  not surprising  since  monovalent haptens inhibit  anaphylaxis and a 
number of related  immediate type allergic  reactions  (13-15).  In view of  the ob- 
scurity  and controversy  surrounding the  human antibody  responsible  for  wheal- 
and erythema response (16),  it  could not have been anticipated  with certainty, 
however, that in the actively sensitized  human  subject, whose wheal-and- 
erythema reaction  to DNP-protein conjugates was classic  in morphology and 
time course,  that hapten inhibition  could here also  be clearly  demonstrable. 
Aside from its pathogenetic significance,  hapten inhibition  furnishes  the only 
means for  identifying  the determinant involved in allergic  skin  reactions. 
The order of inhibitory effectiveness of the haptens tested was : e-DNP lysine 
>  ~-DNP aminocaproic acid >  2,4-dinitrophenol. This order is consistent with 
the af~nities of these haptens for anti-DNP antibodies (~-DNP lysine =  ~DNP 
aminocaproate >> 2,4-dinitrophenol, see references 4 and 8), except that e-DNP 
aminocaproate was less effective than ¢-DNP lysine (Tables I and II). The de- 
creased inhibitory activity of e-DNP aminocaproate in vivo may be ascribed to 
its reversible binding by serum albumin (3), which is present in the skin (17). 
It is generally believed that a fundamental property of immediate type aller- 
gic reactions is their amenability to transfer (to  insensitive recipients)  with 
serum derived from sensitive donors. This property is not, however, always de- 
monstrable. For example, with serum from human beings who gave wheal-and- 
erythema responses to dextran, Kabat was unable to obtain positive transfer 
responses on intradermal injections of quantities of serum containing up to 50 
#g. anti-dextran antibody (16). Likewise, in the present work, undiluted serum 
from the subject who reacted to DNP-HSA did not transfer reactivity to nor- 
mal recipients. These failures with whole serum are readily accounted for by the 
observation that 0.05  ml. of a  whole (unfracfionated) rabbit antiserum pool, 
containing 90 #g. precipitating anti-DNP antibody, was incapable of preparing 
skin sites to react to DNP-HSA, yet 5/zg. of purified antibody, isolated from 
the same antiserum, was competent (Table V). Provisionally, we ascribe the 
unequal effectiveness of antibody in serum and of purified antibody to compe- 
tition between antibodies of a given specificity and indifferent ~'-globulins,  pos- 
sibly for restricted skin sites. Similar competition has been observed in passive 
cutaneous anaphylaxis (18,  19).  It is necessary, therefore, in evaluating the 
competency of a given antigen-antibody system to take into account not only 
the amount of antibody of appropriate specificity, but, at the same time, the • .  S.  FAKAH, M.  KERN~ AND H.  N.  EISEN  1223 
amount of indifferent -g-globulin in the test solution. Purified antibodies become, 
in  this  respect, virtually necessary for assessing  the competency of a  given 
system. 
On the foregoing  grounds it is possible to reconcile  the incompetence of the 
present rabbit anti-DNP sera (unfractionated) with Wood's successful transfers 
using rabbit antipneumococcal polysaccharide sera (20). In our sera, anti-DNP 
antibody is generally about 1 to 3 mg./ml., and amounts to not more than 10 to 
15 per cent of the total -r-globulin. In Wood's sera, which had been prepared for 
therapeutic use, there were 10,000 units of antibody/ml, and it is reasonable to 
assume that in such preparations perhaps 30 per cent of the total ~,-globulin was 
antibody of the designated specificity.  The minimal effective amount of unfrac- 
tionated serum was found by Wood to be 0.0001 ml.; i.e.,  1 unit or 5.7/~g. anti- 
body* in a total of about 18 #g. rabbit "r-globulin. With the DNP system, posi- 
tive reactions have been obtained with 5 #g. purified antibody and significant 
inhibition  was noted when the weight ratio of indifferent "r-globlulin: anti-DNP 
antibody was about 6. The results obtained with rabbit antipneumococcal poly- 
saccharide  antibody and  with  rabbit  anti-DNP  antibody are,  therefore,  in 
remarkably good agreement.  Quantitative  comparison between these systems 
is of interest also in respect to the concentrations of circulating  serum antibodies 
associated with skin responsiveness.  Wood found that human beings treated 
intravenously with rabbit antipneumococcal polysaccharide sera gave wheal- 
and-erythema responses to the corresponding polysaccharide when free anti- 
body levels in serum exceeded 0.1 unit (0.5/zg.)  antibody/ml. (20). In the pres- 
ent study it is estimated that there was about 3 #g. anti-DNP antibody/ml. 
serum of the actively sensitized  human subject (Table I). 
Of the three distinguishable components in papaln digests of rabbit ~/-globu- 
lin, fractions I and II are of particular interest. On the basis of their ability to 
inhibit precipitation specifically, Porter (7) inferred that these fragments have 1 
antigen-combining region per mole  (55,000 molecular weight). Titration with 
hapten of the fractions isolated from papain split anti-DNP antibody has con- 
firmed the univalence of fractions I and II, and demonstrated that the sites on 
these fragments interact just as strongly with homologous haptens as do the 
corresponding sites of intact, bivalent, antibody (8). It is especially interesting 
to note, therefore, that these fractions (I +  H) were not capable of preparing 
skin sites for wheal-and-erythema responses.  These fragments could only, in 
fact, specifically  inhibit the response in otherwise competent sites. From the 
equal persistence in skin sites of Ira-labeled antibody and Ira-labeled fractions 
I +  II, the incompetency of the split products cannot be ascribed to their rapid 
disappearance from injected skin sites (Fig. 2). 
s In the case of rabbit antipneumococcal  polysaccharide, type I, 1 mg. antibody N, isolated 
in a precipitin reaction, corresponds to 1100 mouse protective units (21). 1224  INHIBITION OF  SKIN B-ESPONSES 
The only activity exhibited by univalent  haptens  and  univalent  antibody 
fragments was inhibition  of both active and passive wheal-and-erythema re- 
sponses.  We conclude,  therefore, that mutually multivalent antibody and anti- 
gen are necessary for this allergic reaction in human skin.  By analogy with the 
precipitin  reaction,  the  requirement  for mutual  multivalency indicates  that 
rather large multimolecular complexes, having as a minimum 2 antigen and 2 
antibody molecules  (G>2.B>2), are essential for this response.  These findings 
are in agreement with Ishizaka and Campbell who found that passive cutaneous 
anaphylaxis  (in  guinea  pigs)  is  dependent  on  the  composition  of  antigen- 
antibody complexes:  those composed of 2 antigen  molecules  and  1 antibody 
molecule  (G2"  B) did not have activity, whereas G3" B2 and more complicated 
complexes did (22). 
The prompt and transient inflammatory response  produced with  the aid of 
rabbit  antibody in  human  skin  (wheal-and-erythema)  resembles  closely the 
corresponding  response of rat and guinea pig skin (passive cutaneous anaphy- 
laxis).  Both  responses  are  characterized  by transient  increases  in  capillary 
permeability, and in both immunologically  indifferent  serum proteins (-r-globu- 
lins)  reduce the effectiveness  of a  given amount  of  antibody (Table  IV  and 
references  18,  19). Both responses  can,  moreover, be specifically  inhibited by 
unifunctional haptens  (Table II and reference 15), and require large antigen- 
antibody complexes  in  which each  reactant  is  represented  by more  than  1 
molecule  (see above, and reference  22). The latter requirement has been corre- 
fated with the ability of competent complexes to bind complement (23, 24). 
While there is a high degree of consistency in the immunologic  characteristics 
of passive cutaneous anaphylaxis and of human wheal-and-erythema responses 
to  certain  determinants  (pneumococcal  polysaccharides,  2,4-dinitrophenyl 
group, and probably dextran), these systems do not yet afford a  satisfactory 
explanation  for the  peculiar  and  striking  skin-reactive  properties  of certain 
human  "reaginic"  sera,  the  case  of sera  from  ragweed-sensitive individuals 
being the best known example.  Intradermal injection of normal human beings 
with unfractionated  human serum of this type transfers wheal-and-erythema 
reactivity to ragweed extracts. But these sera give no precipitation on addition 
of antigens which  are effective  in eliciting  the wheal-and-erythema  response. 
While  a number of possible  explanations may be visualized as accounting for 
the differences between ragweed and related systems and the more thoroughly 
defined systems mentioned above, it seems likely that a satisfactory reconcilia- 
tion  of  the  discrepancies  will  require  the  availability  of purified  and  char- 
acterized reactants of reaginic systems. 
SUMMARY 
Wheal-and-erythema  responses  were  studied  in  normal  human  volunteers 
and in a single human subject who is sensitive to the 2,4-dinitrophenyl  group. 
In  the  normal  subjects,  reactive  skin  sites were established  by intradermal F. S. FARAH, M. KERN,  AND H. N. EISEN  1225 
injection of purified rabbit antibody specific for the 2,4-dinitrophenyl group. 
In both the active and passively sensitized subjects, wheal-and-erythema was 
elicited by intradermal injection of a  2,4-dinitrophenyl protein,  but not by 
injection of the same conjugate mixed with certain low molecular weight 2,4- 
dinitrophenyl haptens or with univalent fragments split by papain from anti- 
2,4-dinitrophenyl  antibody.  The  latter  fragments,  unlike  intact,  bivalent, 
antibody, do not sensitize normal  human skin sites.  From these and other 
observations it is concluded that the wheal-and-erythema response in human 
skin requires  mutually multivalent antigen and antibody. This requirement 
suggests that multimolecular complexes,  containing at least 2  antigen and 2 
antibody molecules, are essential in the pathogenesis of this allergic response. 
We wish to thank Mr. Waiter Gray for competent technical assistance. 
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